Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Mangoceuticals, Inc. ( (MGRX) ) just unveiled an announcement.
On April 10, 2025, Mangoceuticals, Inc. issued a total of 335,000 fully-vested shares of common stock as a discretionary bonus to its officers and directors for services rendered in 2025. This issuance was part of the company’s 2022 Equity Plan and included significant allocations to key figures such as CEO Jacob D. Cohen and President Antonios Isaac, highlighting the company’s commitment to rewarding its leadership team.
More about Mangoceuticals, Inc.
YTD Price Performance: -36.95%
Average Trading Volume: 162,814
Technical Sentiment Signal: Strong Buy
Current Market Cap: $10.94M
For an in-depth examination of MGRX stock, go to TipRanks’ Stock Analysis page.